Ultrasound sales turn up for Acuson

Article

Acuson last week downplayedan improvement in its ultrasound sales and net income for thefirst quarter of 1994 (end April 2). However, the results weregood news for the vendor and an ultrasound industry battered bydeclining U.S. purchasing. Net sales

Acuson last week downplayedan improvement in its ultrasound sales and net income for thefirst quarter of 1994 (end April 2). However, the results weregood news for the vendor and an ultrasound industry battered bydeclining U.S. purchasing.

Net sales for the first quarter rose 12% from $82.3 millionin 1993 to $92.8 million this year. Net income shot up a strong31% from $5 million in the first quarter of last year to $6.6million in the same period this year.

"Our first quarter financial results may not be indicativeof the results for the entire year," said Samuel H. Maslak,president and CEO. "Market uncertainties regarding the purchaseof hospital medical equipment will persist for an indeterminateperiod, due to ongoing worldwide medical cost containment pressuresand concern about the potential impacts of U.S. health-care reform."

Acuson may be right in downplaying a possible market upturn.Ultrasound competitor ATL saw revenue drop 6% for the same three-monthperiod, from $81.4 million in 1993 to $75.9 million this year.

"We expect the difficult market conditions in the U.S.to continue for the near term," said Dennis C. Fill, chairmanand CEO.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.